| Stage | SARO | % of rev | MDLN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.6B | 100.00% | $7.9B | 100.00% | MDLN ×4.91 |
| Gross profit | $269M | 16.80% | $1.9B | 24.50% | MDLN +7.7pp |
| Operating income | $168M | 10.53% | $500M | 6.36% | SARO +4.2pp |
| Pre-tax income | $127M | 7.95% | $386M | 4.91% | SARO +3.0pp |
| Net income | $97M | 6.08% | $318M | 4.05% | SARO +2.0pp |
| Stage | SARO | MDLN | Gap · A − B |
|---|---|---|---|
| Revenue | $1.6B100.00% | $7.9B100.00% | MDLN ×4.91 |
| Gross profit | 16.80%$269M | 24.50%$1.9B | MDLN +7.7pp |
| Operating income | 10.53%$168M | 6.36%$500M | SARO +4.2pp |
| Pre-tax income | 7.95%$127M | 4.91%$386M | SARO +3.0pp |
| Net income |
| 6.08%$97M |
| 4.05%$318M |
| SARO +2.0pp |
No shared counterparties.